The 15 linked references in paper R. Samsonov B., V. Burdakov S., T. Shtam A., Z. Radzhabova A., Y. Cheburkin V., D. Vasilyev A., E. Tsyrlina V., S. Titov E., M. Ivanov К., M. Filatov V., L. Berstein M., N. Kolesnikov N., А. Malek V., Р. Самсонов Б., В. Бурдаков С., Т. Штам А., Раджабова А. З., Ю. Чебуркин В., Д. Васильев А., Е. Цырлина В., С. Титoв Е., М. Иванов К., М. Филатов В., Л. Берштейн М., Н. Колесников Н., А. Малек В. (2017) “МЕТОД ДИФФЕРЕНЦИАЛЬНОЙ ДИАГНОСТИКИ УЗЛОВЫХ ЗАБОЛЕВАНИЙ ЩИТОВИДНОЙ ЖЕЛЕЗЫ: АНАЛИЗ КОМБИНАЦИИ МИКРОРНК (МИРНК-21, -181A И -146А) // ANALYSIS OF A MIRNA SET (MIR-21, -181A, AND -146A) AS A METHOD OF DIFFERENTIAL DIAGNOSIS OF THYROID NODULES” / spz:neicon:ogsh:y:2017:i:2:p:16-24

  1. Dean D. S., Gharib H. Epidemiology of thyroid nodules. Best Pract Res Clin Endocrinol Metab 2008;22(6):901–11. DOI: 10.1016/j.beem.2008.09.019. PMID: 19041821.
  2. Luster M., Weber T., Verburg F. A. Differentiated thyroid cancer-personalized therapies to prevent overtreatment. Nat Rev Endocrinol 2014;10(9):563–74. DOI: 10.1038/nrendo.2014.100. PMID: 24981455.
  3. Kato M. A., Fahey T. J. Molecular markers in thyroid cancer diagnostics. Surg Clin North Am 2009;89 (5):1139–55. DOI: 10.1016/j. suc. 2009.06.012. PMID: 19836489.
  4. Zipeto M. A., Jiang Q., Melese E., Jamieson C. H. RNA rewriting, recoding, and rewiring in human disease. Trends Mol Med 2015;21(9):549–59. DOI: 10.1016/j.molmed.2015.07.001. PMID: 26259769.
  5. Di Leva G., Garofalo M., Croce C. M. MicroRNAs in cancer. Ann Rev Pathol 2014;9:287–314. DOI: 10.1146/annurevpathol-012513–104715. PMID: 24079833.
  6. Nikiforova M. N., Chiosea S. I., Nikiforov Y. E. MicroRNA expression profiles in thyroid tumors. Endocr Pathol 2009;20(2):85–91. DOI: 10.1007/s12022-009-9069-z. PMID: 19352602.
  7. Sato-Kuwabara Y., Melo S. A., Soares F. A., Calin G. A. The fusion of two worlds: non-coding RNAs and extracellular vesicles-diagnostic and therapeutic implications (Review). Int J Oncol 2015;46(1):17–27. DOI: 10.3892/ijo.2014.2712. PMID: 25338714.
  8. Zhang J., Li S., Li L. et al. Exosome and exosomal microRNA: trafficking, sorting, and function. Genomics Proteomics Bioinformatics 2015;13(1):17–24. DOI: 10.1016/j.gpb.2015.02.001. PMID: 25724326.
  9. Ye S. B., Li Z. L., Luo D. H. et al. Tumorderived exosomes promote tumor progression and T-cell dysfunction through the regulation of enriched exosomal microRNAs in human nasopharyngeal carcinoma. Oncotarget 2014;5(14):5439–52. DOI: 10.18632/oncotarget.2118. PMID: 24978137.
  10. Challagundla K. B., Wise P. M., Neviani P. et al. Exosome-mediated transfer of microRNAs within the tumor microenvironment and neuroblastoma resistance to chemotherapy. J Natl Cancer Inst 2015;107(7). DOI: 10.1093/jnci/djv135. PMID: 25972604.
  11. Yu S., Liu Y., Wang J. et al. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. J Clin Endocrinol Metab 2012;97 (6):2084–92. DOI: 10.1210/jc.2011–3059. PMID: 22472564.
  12. Lee J. C., Zhao J. T., Clifton-Bligh R. J. et al. MicroRNA-222 and microRNA146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Cancer 2013;119(24):4358–65. DOI: 10.1002/cncr.28254. PMID: 24301304.
  13. 5;51 (1):77–83. DOI: 10.1016/j.oraloncology.2014.10.006. PMID: 25456009. 20. Ferracin M., Lupini L., Salamon I. et al. Absolute quantification of cell-free microRNAs in cancer patients. Oncotarget 2015;6(16):14545–55. DOI: 10.18632/oncotarget.3859. PMID: 26036630.
  14. Chevillet J. R., Kang Q., Ruf I. K. et al. Quantitative and stoichiometric analysis of the microRNA content of exosomes. Proc Natl Acad Sci USA 2014;111(41):14888–93. DOI: 10.1073/pnas.1408301111. PMID: 25267620.
  15. Cha D. J., Franklin J. L., Dou Y. et al. KRAS-dependent sorting of miRNA to exosomes. Elife 2015;1(4): e07197. DOI: 10.7554/eLife.07197. PMID: 26132860.